FDA Inspection 1043588 — Christopher M. Pieczonka, M.D.
The FDA completed an inspection of Christopher M. Pieczonka, M.D. on February 22, 2018 in Syracuse, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 22, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Syracuse, NY (United States)
Additional Details
Clinical Investigator (CI)